Evidence map›Paper›PMID 27030919›Full record

ArticleInfectious diseases (London, England)2016

Lethal neonatal meningoencephalitis caused by multi-drug resistant, highly virulent Escherichia coli.

Junaid Iqbal, Kevin R Dufendach, John C Wellons, Maria G Kuba, Hilary H Nickols, Oscar G Gómez-Duarte, James L Wynn

Abstract readCase Reports
In one paragraph

Article in Infectious diseases (London, England), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.6field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 23 citations in OpenAlex.

  1. Whole-genome analysis of fiveMicrobiology spectrum · 2025
    Article
  2. Article
  3. Case report: A rare multidrug-resistantFrontiers in public health · 2023
    Article
  4. Prevalence ofTropical medicine and infectious disease · 2022
    Article
  5. Nucleotide receptors mediate protection against neonatal sepsis and meningitis caused by alpha-hemolysin expressing Escherichia coli K1.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2022
    Article
  6. Article
  7. Article
  8. Comparative Pathogenomics ofInfection and immunity · 2021
    Article
  9. Strategies to Tackle Antimicrobial Resistance: The Example ofInternational journal of molecular sciences · 2021
    Review
  10. Article
  11. Article
  12. Article
  13. Phylogenomic Analysis of Extraintestinal PathogenicAntimicrobial agents and chemotherapy · 2019
    Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Junaid Iqbala Department of Pediatrics , Vanderbilt University , Nashville , TN , USA ;
Kevin R Dufendacha Department of Pediatrics , Vanderbilt University , Nashville , TN , USA ;
John C Wellonsb Department of Neurosurgery , Vanderbilt University , Nashville , TN , USA ;
Maria G Kubac Department of Pathology, Microbiology and Immunology , Vanderbilt University , Nashville , TN , USA ;
Hilary H Nickolsc Department of Pathology, Microbiology and Immunology , Vanderbilt University , Nashville , TN , USA ;
Oscar G Gómez-Duartea Department of Pediatrics , Vanderbilt University , Nashville , TN , USA ;
James L Wynnd Department of Pediatrics , University of Florida , Gainesville , FL , USA.
Vanderbilt University · USUniversity of Florida · US

Funding

The Vanderbilt Institute for Clinical and Translational Research (VICTR)UL1TR000445 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNARD, GORDON RAPHAEL · 2012 to 2016
$41.4M
Preventing Prematurity and Poor Pregnancy Outcomes Training GrantT32HD068256 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI REESE, JOHN JEFFREY, STARK, ANN R · 2011 to 2015
$1.2M
The Role of the Inflammasome in Neonatal SepsisK08GM106143 · NIGMS · VANDERBILT UNIVERSITY · PI WYNN, JAMES LAWRENCE · 2013 to 2017
$875k
NCATS NIH HHS UL1 TR000445NCATS NIH HHS UL1TR000445NICHD NIH HHS T32 HD068256NIGMS NIH HHS K08 GM106143NIGMS NIH HHS K08GM106143
6 · The paper itself

Abstract

Neonatal meningitis is a rare but devastating condition. Multi-drug resistant (MDR) bacteria represent a substantial global health risk. This study reports on an aggressive case of lethal neonatal meningitis due to a MDR Escherichia coli (serotype O75:H5:K1). Serotyping, MDR pattern and phylogenetic typing revealed that this strain is an emergent and highly virulent neonatal meningitis E. coli isolate. The isolate was resistant to both ampicillin and gentamicin; antibiotics currently used for empiric neonatal sepsis treatment. The strain was also positive for multiple virulence genes including K1 capsule, fimbrial adhesion fimH, siderophore receptors iroN, fyuA and iutA, secreted autotransporter toxin sat, membrane associated proteases ompA and ompT, type II polysaccharide synthesis genes (kpsMTII) and pathogenicity-associated island (PAI)-associated malX gene. The presence of highly-virulent MDR organisms isolated in neonates underscores the need to implement rapid drug resistance diagnostic methods and should prompt consideration of alternate empiric therapy in neonates with Gram negative meningitis.

Indexed as

Anti-Bacterial AgentsDNA, BacterialDrug Resistance, Multiple, BacterialEscherichia coliEscherichia coli InfectionsFatal OutcomeFemaleHumansInfantInfant, NewbornMeningoencephalitisAnti-Bacterial AgentsDNA, BacterialEscherichia colihypervirulencemeningitismeningoencephalitismulti-drug resistanceneonate

Identifiers

PMID27030919
PMCPMC4818964
OpenAlexW2288428460

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.